Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in two upcoming ...

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) has received a consensus recommendation of “Moderate Buy” ...

TD Cowen initiated coverage of Crinetics (CRNX) with a Buy rating and no price target The firm says Crinetics is “revered” in the endocrine ...

Days after President Trump took office, he put a sudden halt to the nation’s public-facing scientific activities. He stopped scientific meetings and grant reviews. Public communications stopped ...

Crinetics’ lead development candidate, paltusotine, is the first investigational once-daily, oral, selective somatostatin ...

Imposter syndrome is when you doubt your own skills and successes. You feel you're not as talented or worthy as others believe, and you're scared that one day, people will realize that.

Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited. In a cohort of patients with liver metastases ...

Lymphoma and leukemia: Lymphoma and acute leukemias, cancers of the white blood cells, are most typically associated with night sweats. Carcinoid syndrome: This is caused by a carcinoid tumor, which ...

Klinefelter syndrome is a genetic condition that affects only males. Here's what you should know about the causes, symptoms, and treatment options for the condition. Klinefelter syndrome is a genetic ...

The hormones can cause symptoms that can seem separate to the cancer. These symptoms include: skin flushing diarrhoea wheezing fast heart beat Doctors call this collection of symptoms carcinoid ...

Background Atypical carcinoids (AC) of the lung are rare intermediate-grade neuroendocrine neoplasms. Prognostic factors for these tumours are undefined. Methods Our cooperative group retrieved data ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified ...